Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 16Colorectal Neoplasms 3Postoperative Complications 2Anastomotic Leak 2Transfusion Reaction 1Recurrence 1Rectal Cancer Stage T1-T2 1Pathologic Complete Response 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1Colitis, Ischemic 1Coitus 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Proctectomy × Clear all
NCT03899870 2019-04-02

Factors Predicting Recurrence in Rectal Cancer After Surgery

Université de Sousse

Completed
188 enrolled
Gastrointestinal

Rectal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡